Acadia Pharmaceuticals buy Mizuho
Start price
28.02.24
/
50%
€21.60
Target price
28.02.25
€36.02
Performance (%)
-36.39%
Price
20.05.24
€13.74
Summary
This prediction is currently active. The BUY prediction by Mizuho for Acadia Pharmaceuticals is performing very badly with a performance of -36.39%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | -2.380% | -2.380% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by Mizuho for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Mizuho from $40.00 to $39.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Mizuho for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
29.12.23
29.12.23
€36.19
29.12.24
29.12.24
-51.62%
20.05.24
20.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.40
06.11.23
06.11.23
€32.59
06.11.24
06.11.24
-38.66%
20.05.24
20.05.24